Govt approves stepping up of Remdesivir Drug production

Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week to fight against COVID.

| April 15, 2021


#Remdesivir   #CovidVaccine   #Corona   #Coronavaccine   #NationalPharmaceuticalPricingAuthority   #DCGI   #Vaccineexport  
The government has reviewed the issue of availability of Remdesivir Drug and has decided to increase the production and decrease the price of the drug. The government has​ also issued a ban on its export. Remdesivir is the first drug approved by the FDA for treating the SARS-CoV-2 virus. 
 
The review was done by Mansukh Mandaviya, Minister of State, For Ports, Shipping and Waterways (Independent Charge) and Chemicals & Fertilizers, Government of India in meetings with the all-existing manufacturers of the Remdesivir drug and other stakeholders on 12th and 13th April 2021.
 
As an additional measure, Remdesivir, API and formulation were placed under the export ban by DGFT to increase the supply of Remdesivir in the domestic market. On Government intervention, Remdesivir supplies of approximately 4 lakh vials meant for export is being diverted by manufacturers to fulfil the domestic requirement. EOU/SEZ units are also being enabled to supply to the domestic market.
 
Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week to fight against COVID. Manufactures of Remdesivir have been directed to give priority to fulfil hospital/institutional level supplies. National Pharmaceutical Pricing Authority (NPPA) is continuously monitoring the availability of Remdesivir.
 
Also, DCGI has directed enforcement authorities of states and central government to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir.
 
The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers. Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month.
 

Comments

 

Other News

CoWIN to have new security feature from Saturday

The CoWIN system, the overarching digital platform for citizens seeking appointment for the Covid-19 vaccine, is introducing a new four-digit security code” in the application from Saturday to minimise a peculiar error and subsequent inconvenience to citizens. “It has been notic

Learn from Mumbai model to manage oxygen supply: supreme court

Mumbai, once the epicentre of the pandemic in India, has emerged as a model for all others in mitigating the crisis. The supreme court on Wednesday said the central government should adopt and take lessons from the Mumbai model to manage liquid medical oxygen supply for Covid-19 patients in Delhi.

‘What do they know of history who only history know?’

A Functioning Anarchy? Essays For Ramachandra Guha Edited by Srinath Raghavan and Nandini Sundar Penguin Random House India / 392 pages / Rs 650 In a long and versatile career spanning thirty-five years, Ramachandra Guha has prod

BMC commissioner urges Mumbaikars to come forward for testing

To take preventive steps early and save lives, BrihanMumbai municipal corporation (BMC) commissioner Iqbal Singh Chahal has urged citizens to come forward and get themselves tested.   Mumbai has seen a dip in Covid-19 cases in the last few days after an unprecedented increase in cases s

India records over 3 lakh recoveries, fresh cases down

India reported 3,68,147 new cases on Monday, a number lower than the 4 lakh-plus recorded in the weekend. Also, more than 29.16 crore Covid tests were conducted across the country. As many as 29,16,47,037 have been conducted as on date. India’s cumulative recoveries now stand

This Maharashtra district set up oxygen plants just ahead of the curve

Nandurbar, a tribal and hilly district in Maharashtra with a population of 20 lakh, is an unlikely contender for setting a precedent for the rest of India, but under the leadership of district collector Dr Rajendra Bharud, it took several measures to augment medical oxygen supply ahead of the second wave o

Visionary Talks with R P Singh, National Spokesperson, BJP



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter